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ABSTRACT 
Genetic correlation is a key population parameter that describes the shared genetic architecture 
of complex traits and diseases. It can be estimated by current state-of-art methods, i.e. linkage 
disequilibrium score regression (LDSC) and genomic restricted maximum likelihood (GREML). 
The massively reduced computing burden of LDSC compared to GREML makes it an attractive 
tool, although the accuracy (i.e., magnitude of standard errors) of LDSC estimates has not been 
thoroughly studied. In simulation, we show that the accuracy of GREML is generally higher than 
that of LDSC. When there is genetic heterogeneity between the actual sample and reference data 
from which LD scores are estimated, the accuracy of LDSC decreases further. In real data 
analyses estimating the genetic correlation between schizophrenia (SCZ) and body mass index, 
we show that GREML estimates based on ~150,000 individuals give a higher accuracy than 
LDSC estimates based on ~400,000 individuals (from combined meta-data). A GREML genomic 
partitioning analysis reveals that the genetic correlation between SCZ and height is significantly 
negative for regulatory regions, which whole genome or LDSC approach has less power to 
detect. We conclude that LDSC estimates should be carefully interpreted as there can be 
uncertainty about homogeneity among combined meta-data sets. We suggest that any interesting 
findings from massive LDSC analysis for a large number of complex traits should be followed 
up, where possible, with more detailed analyses with GREML methods, even if sample sizes are 
lesser. 
MAIN TEXT 
Genetic correlation is a key population parameter that describes the shared genetic 
architecture of complex traits and diseases 1-3. The genetic correlation is the additive genetic 
covariance between two traits scaled by the square root of the product of the genetic variance for 
each trait (i.e., the geometric mean of the trait variances). The sign of the correlation shows the 
direction of sharing, and the parameter definition is based on genetic variants across the allelic 
spectrum. Methods to estimate genetic correlation based on genetic covariance structure are well 
established for both quantitative and disease traits, e.g. (restricted) maximum likelihood for 
linear mixed models (LMM) 4-6. Genetic covariance structure can be derived from phenotypic 
records using pedigree information in twin or family-based designs 7. Recently, genome-wide 
single nucleotide polymorphism (SNP) data have been used to construct a genomic relationship 
matrix for the genetic covariance structure in LMM that captures the contribution of causal 
variants that are in linkage disequilibrium (LD) with the genotyped SNPs4; 8; 9. Such estimates 
assume that the genetic correlation estimated from common SNPs is representative of the 
parameter that depends on all genetic variants; this seems like a reasonable assumption. 
In contrast to the genomic restricted maximum likelihood (GREML) approach, a linkage 
disequilibrium score regression (LDSC) 10; 11 method does not require individual-level genotype 
data but instead uses GWAS summary statistics, regressing association test statistics of SNPs on 
their LD scores. The LD score of a SNP is the sum of LD r2 measured with all other SNPs, and 
can be calculated in a reference sample of the same ethnicity when individual genotype data are 
not available for the GWAS sample, under the assumption that the GWAS sample has been 
drawn from the same ethnic population as the reference sample used to calculate the LD scores. 
The method exploits the relationship between association test statistic and LD score expected 
under polygenicity. Because of this simplicity, and the massively reduced computing burden in 
terms of memory and time, it is feasible for LDSC to be applied to a large number of multiple 
traits, e.g. Bulik-Sullivan et al. 11, Zheng et al. 12, Finucane et al. 13 .  
Given the attractiveness of LDSC for a massive analysis of many sets of GWAS 
summary statistics, it has been widely used in the community. However, genetic correlations 
estimated by LDSC are often reported without caution although the approach is known to be less 
accurate, compared to GREML11. In fact, the accuracies of LDSC estimates have not been 
thoroughly studied.  
In this report, we compare both the bias (difference between the simulated true value and 
estimated value) and accuracy (i.e. magnitude of the standard error of an estimate, SE) between 
GREML and LDSC for estimation of genetic correlation. We find that both methods show little 
evidence of bias. However, LDSC is less accurate as reported in Bulik Sullivan et al.11, with SE 
at least more than 1.5-fold higher than that of GREML regardless of the number of samples in 
data used to estimate the genetic correlation. When decreasing the number of SNPs, the accuracy 
of LDSC decreases further. When increasing the degree of genetic heterogeneity between the 
actual sample and reference data from which LD scores are estimated, the SE of LDSC estimates 
are up to 3-fold larger than those of the GREML estimates. We also show that GREML is more 
accurate in genomic partitioning analyses over LDSC or stratified LDSC (sLDSC). In genomic 
partitioning analyses the genetic parameters are estimated for genomic subsets defined by user-
specified annotations. In analyses of real data, we show that GREML is more accurate and 
powerful, e.g. GREML estimates based on ~ 150,000 individuals give a higher accuracy than 
LDSC estimates based on 400,000 individuals in estimating genetic correlation between 
schizophrenia (SCZ) and body mass index (BMI) (-0.136 (SE=0.017) and p-value=4.54E-15 for 
GREML vs. -0.087 (SE=0.019) and p-value=4.91E-06 for LDSC). In these analyses, the 
GREML estimate is based on UK sample only whereas the LDSC estimate is based on combined 
meta-data sets among which there is uncertainty about homogeneity. Furthermore, a GREML 
genomic partitioning analysis reveals that the genetic correlation between SCZ and height is 
significantly negative for regulatory regions, which is less obvious by LDSC both when using 
whole-genome or partitioned estimates of genetic correlation.  
In the main methods, we used GREML14; 15 and LDSC10; 11 to compare their estimates of 
genetic correlation using simulated as well as real data. Simulations were based on UK Biobank 
imputed genotype data (UKBB16) after stringent quality control (QC) (see Supplemental 
Methods). We calculated a ratio of empirical SE and its 95% confidence interval (CI) to assess 
the accuracy of the methods for each set of simulated data. The 95% CIs of SE were estimated 
based on the delta method17. When estimating genetic correlation using simulated phenotypes 
based on UKBB genotype data we found that the estimates were unbiased for both GREML and 
LDSC (Figure S1), but the SE of GREML was at least 1.5 times smaller than that of LDSC 
(Figure 1). The ratio of the empirical SE from LDSC to GREML was increased up to 3.5-fold 
when using a smaller number of SNPs (Figure 1). All values of the ratio were significantly 
different from 1. It is notable that the SE of GREML estimates showed almost no difference 
across different numbers of SNPs whereas that of LDSC estimates gradually increased with a 
smaller number of SNPs (Figure S2). The ratio was invariant to sample size (Figure S3). As 
expected, when using the intercept constrained to zero, LDSC estimates were substantially 
biased when there were overlapping samples (Figure S4). We also explored alternative genetic 
architectures (Figure S5), which consistently showed that GREML gives a smaller SE than 
LDSC in any scenario.  
 To explore the stability of the accuracy for both methods, we used two additional 
genotype data sets without imputation, Wellcome trust case control consortium 2 (WTCCC218-21 
) and genetic epidemiology research on adult health and aging cohort (GERA22; 23), which are 
publicly available (see Supplemental Methods for detailed data descriptions). We also used 
UKBB raw (non-imputed) genotype data (UKBBr). We calculated the correlation between the 
LD scores for the HapMap3 SNPs estimated based on the 1KG CEU reference sample 
(downloaded from https://data.broadinstitute.org/alkesgroup/LDSCORE/) and those based on in-
sample genotype data, i.e. UKBB, WTCCC2, GERA and UKBBr data set (Table 1). We found 
that the WTCCC2, GERA or UKBBr (raw) genotypes were less similar to the 1KG reference 
genotypes, compared to the UKBB (imputed) genotypes (noting that UKBB samples had been 
imputed to the combined data of 1KG reference and UK10K data). Table 2 shows that the SE 
ratio of LDSC estimate to GREML estimate was higher for WTCCC2, GERA or UKBBr than 
that for UKBB. Figure 2 shows that the accuracy of GREML was consistent across different data 
sets, whereas that of LDSC was decreased for WTCCC2, GERA or UKBBr, compared to UKBB 
data set. This was probably due to higher (or lower) correlation between LD scores based on the 
1KG reference and the in-sample genotype data sets (Table 1) which might positively or 
(negatively) affect the accuracy of LDSC estimates. For WTCCC2, GERA and UKBBr data, the 
SE ratio of LDSC to GREML based on different number of individuals is shown in Figures S6, 
S7 and S8. 
 Genome partitioning analyses are an emerging tool to estimate the genetic variance and 
covariance explained by functional categories (e.g. DNase I hypersensitive sites (DHS) and non-
DHS 24). Currently, genomic partitioning analyses focus on SNP-heritability enrichment 
analyses, formally testing for enrichment of signal compared to the expectation that the estimates 
are proportional to the number of SNPs allocated to each annotation. Considering genomic 
partitioning in cross-disorder analyses is a natural extension to identify regions where genetic 
correlations between disorders are highest and lowest. Here, we assessed the performance of the 
methods in the context of genome partitioning analyses using simulated phenotypes based on 
UKBB genotype data. A better LDSC approach to estimate genetic correlation for each category 
might be sLDSC, stratifying by genomic annotation; however, this method is currently under 
development (i.e. there is software (see Web Resources), but there is no published document or 
paper verifying the method). Nonetheless, since the sLDSC is available to the research 
community, we applied both LDSC and sLDSC to estimate partitioned genetic correlations for 
the simulated data (Supplemental Methods). For genome partitioning analyses, we showed that 
LDSC estimates of genetic correlation were biased whether using LD-scores estimated from the 
1KG reference or in-sample data (UKBB) while GREML estimates gave unbiased estimates for 
each functional category (Figure 3). sLDSC estimates were unbiased only when using LD-scores 
from the in-sample data, and their SEs are relatively larger than those of GREML or LDSC 
(Figure 3). This was probably due to the fact that the different distribution of causal variants and 
their effects between DHS and non-DHS regions were better captured by an explicit covariance 
structure fitted in GREML. We also applied the methods to a range of simulation scenarios and 
found similar results in that GREML performed better than LDSC or sLDSC (Figure S9 and 
Table S1), which was consistent with the previous results (Figures 1 and 2). It is notable that in a 
deliberately severe scenario (e.g. causal variants are simulated only within few kb of a boundary) 
GREML could give biased estimation of genetic correlation 13; 24 . 
While focusing on the accuracy of genetic correlation estimates, there is an important 
implication for the bias in SNP-heritability estimates for both GREML and LDSC (Figure S10). 
When using the WTCCC2, GERA and UKBBr data, which were less similar to the 1KG 
reference genotypes, compared to the UKBB data, LDSC estimates were substantially biased 
whereas GREML estimates were close to the true value in estimation of SNP heritability (Figure 
S10). However, this result is well known and LDSC was not recommended for SNP heritability 
by the original authors 10, but rather for relative enrichment analysis. Despite this, LDSC is 
widely used for SNP-heritability estimation (because it is quick and simple). Thus, for 
completeness we include analyses for different scenarios to quantify the properties of the 
methods. When reducing the number of SNPs, estimated SNP-heritabilities from LDSC were 
consistently unbiased; however, those from GREML were proportionally underestimated (Figure 
S11). When using non-HapMap3 SNPs, LDSC estimates were consistently biased (Figure S12) 
and less accurate, compared to GREML estimates (Figures S13 and S14), which probably 
explains why LDSC is implemented using only HapMap3 SNPs. Although the genetic 
correlation is robust to such biasedness 4; 11, SNP-heritability itself should be carefully 
interpreted for both GREML and LDSC. We also noted that LDSC and sLDSC estimates for 
SNP-heritability were biased in the genome partitioning analysis (Figure S15) although the 
estimated enrichment was close to the true value when using sLDSC and in-sample LD scores 
(Figure S15). 
 We used real phenotype and individual genotype data from the Psychiatric Genomics 
Consortium (PGC) and UKBB to estimate genetic variance and covariance between SCZ and 
BMI using LDSC and GREML (Table 3 and Figure S16). We also used publicly available 
GWAS summary statistics for LDSC to see how much the SE of estimates could be reduced by 
increasing the number of samples and number of SNPs. For real data analyses, we obtained 
theoretical SE to assess the accuracy of the methods. GREML and LDSC estimates for the SNP-
heritability were 0.192 (SE 0.004) and 0.280 (SE 0.016) for SCZ and 0.184 (SE 0.004) and 0.255 
(SE 0.014) for BMI. The notable difference between GREML and LDSC was probably because 
of a relatively small number of SNPs (500K) that might result in underestimated GREML SNP-
heritability (see Figure S11). This is one of the caveats of using GREML with real data that 
usually comprise multiple cohorts genotyped on different platforms, such that, even with 
imputation, the overlapping set of SNPs imputed with high confidence may be limited. The 
estimated genetic correlation for GREML and LDSC was -0.136 (SE 0.017) and -0.173 (SE 
0.031). This indicated that the GREML estimate was 3.5 and 1.8 times more precise than LDSC 
estimates for the SNP-heritability and genetic correlation, respectively. For LDSC, we also 
considered using additional GWAS summary statistics from publicly available resources25; 26. 
The sample sizes used for additional LDSC analyses (LDSC-meta) are summarized in Table 3. 
The estimated SNP-heritability was 0.259 (SE 0.019) for SCZ and 0.121 (SE 0.007) for BMI, 
and the estimated genetic correlation was -0.087 (SE 0.019). Although sample size was increased 
2.7-fold, the SE of LDSC estimate was not smaller than that for GREML estimate (SE = 0.017 
vs. 0.019, and p-value = 4.54E-15 vs. 4.91E-06 for GREML vs. LDSC) (Table 3). It should be 
noted that GREML estimates used a homogeneous population (within UK and after stringent QC 
excluding population outliers) whereas LDSC-meta1 and -meta2 were based on combined meta-
data sets consisting of ~ 80 different studies for which there is much more uncertainty about 
homogeneity than when using a single study cohort such as UKBB. The large difference of the 
estimates between LDSC and LDSC-meta1 (or -meta2) was probably due to the fact that 
heterogeneity among the 80 different studies resulted in underestimation of the common genetic 
variance and covariance, and that the difference of LD scores between the target and 1KG 
reference data would bias the LDSC estimates as shown in Figure S10. We also analysed height 
data27 and found a similar pattern in that GREML estimates were more accurate than LDSC 
estimates whether using the same data or using additional GWAS summary statistics for LDSC 
(Figure S17 and Table S2). 
In the real data analyses, we carried out a functional category analysis partitioning the 
genome into regulatory, DHS, intronic and intergenic regions using GREML (Figure 4 for 
SCZ/height and Figure S18 for SCZ/BMI). For SCZ and height, the genetic correlation for the 
regulatory region was negative and significantly different from 0 (p-value = 0.0028; Figure 4). 
We also compared the results with the LDSC genetic correlation estimation (Figure S19 and 
S20), and show that the estimates were similar between LDSC and GREML. However, GREML 
had a lower p-value (0.0028 in Figure 4) than LDSC using LD-scores from the 1KG reference 
data (p-value = 0.04) or using LD-scores from the in-sample data (p-value = 0.007). We note that 
current sLDSC software does not provide a SE of estimated partitioned genetic correlation for 
each category; therefore we did not attempt using the software for the real data analysis. For 
SNP-heritability estimation, the SE of the estimate for each category was much lower for 
GREML than sLDSC, ranging from 2.2 to 5.9-fold (Table S3). 
Box 1. Summary points 
1. GREML and LDSC can both provide unbiased estimates of the genetic correlation between 
two traits. GREML requires individual level genotype data, while LDSC requires only 
association summary statistics and LD scores per SNP. If LD scores have been calculated from 
the same sample as the association statistics, then GREML and LDSC provide similar estimates 
of the genetic correlation. However, in practice LD scores are estimated from external reference 
samples of the same broad ethnicity, which can lead to bias in the estimates (Figure S21 and 
S22). As a rule of thumb, when LDSC and GREML estimates are dissimilar, we recommend 
reporting the estimate with a lower SE. The theoretical SE of the estimates is a reliable indicator 
to determine the better estimator, which agrees well with the empirical SE (from simulation 
replicates) (Figure S23).  
2. When combining multiple data sets to estimate genetic correlations between multiple traits, it 
is possible, in practice, that the number of SNPs remaining after QC is relatively small. When the 
number of available SNPs is small, the SE of LDSC estimates for genetic correlation can be 
increased relatively more, compared to that of GREML estimates (Figure S2).  
3. SNP-heritability has a different property, compared to genetic correlation since the latter is 
robust to biased estimation of genetic variance and covariance (presumably the biases occur in 
the numerator and denominator and hence approximately cancel out)4; 11. Especially when using 
a small number of SNPs (< 500K) for GREML or when using multiple meta-data sets for LDSC, 
estimated SNP-heritability itself should be reported with caution as both methods can give biased 
estimates.  
4. When using a study cohort, it is desirable to measure heterogeneity between the cohort and 
1KG reference data (e.g. measuring the correlation between LD scores estimated based on the 
cohort and 1KG reference data as in Table 1). If the correlation is not close to one, LDSC 
estimates should be carefully interpreted. We recommend that when GWAS summary statistics 
are provided, cohort specific LD scores are provided also. It is also warranted that an optimal 
approach to meta-analyse LD scores across multiple cohorts should be developed to improve 
LDSC performance 28.  
5. When using extensive meta-data that possibly include heterogeneous sources, there are two 
problems. Firstly, the LD scores estimated from  reference samples such 1KG reference may be a 
poor representation of the LD scores of the heterogeneous meta-data, such that the accuracy of 
LDSC decreases. Second, the distribution of causal variants and pleiotropic effects may be 
different between heterogeneous sources such that the estimates can be biased (capturing only 
common effects between heterogeneous sources). This implies that LDSC estimates should be 
reported with caution when using extensive meta-data sets (Table 3). 
6. One of advantages of having access to individual-level genotype data comes when more 
detailed analyses are required, such as genomic partitioning analyses. As shown in Figure 4, a 
GREML genomic partitioning analysis reveals a significant negative genetic correlation between 
SCZ and height for the regulatory region, which genome-wide GREML or LDSC approach has 
less power to detect.  
 
 LDSC and GREML are the methods that have been widely used in estimating genetic 
correlation, shedding light on the shared genetic architecture of complex traits, based on 
genome-wide SNPs. Two critical parameters for assessing methods are bias (whether the 
estimates over replicated analyses differ from the true value) and accuracy (reflected by the 
standard error of the estimate). Although the property of the accuracy of GREML has been 
thoroughly studied and tested 29; 30, that of LDSC has not been sufficiently investigated. In this 
report, we compare the accuracy of GREML and LDSC estimates based on various scenarios 
using simulated as well as real data sets, and draw simple but useful guidelines (Box 1). 
Both GREML and LDSC are methods that aim to estimate the same genetic correlation 
parameter based on genetic variants across the allelic spectrum as defined earlier and the 
definition is invariant across the methods. The estimates from both GREML and LDSC are valid 
if all required assumptions are met. GREML estimates variance/covariance components based on 
genetic covariance structure estimated from available (in-sample) individual genotypes; whereas 
LDSC estimates variance/covariance components based on association test statistics corrected 
for LD structure inferred from the markers in the reference panel (e.g. 1KG of the same 
ethnicity). The underlying assumption is that the samples generating the GWAS summary 
statistics are drawn from the same population as the samples generating the LDSC statistics, but 
here we showed that there can be LD-structure (LD-scores) differences between in-sample and 
reference data, which impacts parameter estimations (Tables 1 and 2 and Figure S10).  
 The reduced computing burden of LDSC over GREML makes it the method of choice for 
generating a quick overview of the genetic relationship between disorders (Table S4). However, 
our results suggest that important associations could be overlooked. For example, Bulik-Sullivan 
et al.11 reported a negative genetic correlation between BMI and SCZ estimated by LDSC 
(Estimate = -0.095, SE = 0.025 with p-value = 1.75E-4) which was not significant after 
Bonferroni correction for the multiple testing. Because of the limited power from LDSC 
analysis, the shared genetic architecture between BMI and SCZ, perhaps, has had less attention 
than it is due. We confirmed the negative genetic correlation between BMI and SCZ with a 
greater confidence (Estimate = -0.136, p-value = 4.54E-15) using GREML. A second example is 
in analyses investigating the shared genetic architecture between height and SCZ, in which 
epidemiological evidence points to a negative association 31, supported by genetic analyses 32. 
However, there was no evidence of genetic correlation between height and SCZ in whole-
genome level analyses of Bulik-Sullivan et al. 11 (Estimate = -0.002, SE = 0.022). We used a 
GREML genomic partitioning analysis and found a significant negative genetic correlation 
between height and SCZ for the regulatory region (Figure 4). It was noted that the regulatory 
region was highly enriched for height (Estimate = 0.094, p-value = 7.60E-92 in Table S3), which 
intuitively supports a significant genetic correlation with SCZ for the region. As shown in Figure 
3 and Figure S15, the GREML estimate was closer to the true values with a lower SE than LDSC 
or sLDSC estimate in simulated data. For the real data analyses (Table S3), GREML had more 
accurate SNP-heritability estimates (lower SE) than sLDSC. Moreover, the sum of each category 
matched well with the estimate of the whole-genome for GREML whereas this was not the case 
for sLDSC (Tables S3). 
 Here we focused on genetic correlation estimates, and did not consider a number of 
alternative approaches that have been explored in detail for estimation of SNP-heritability, e.g. 
LDAK approach33, Weighted genomic relationship matrix34, MAF stratified29 and LD-MAF 
stratified approaches 35. It was beyond the scope of our study to assess if biasedness and 
accuracy can be improved with these methods, although a general observation is that biases in 
SNP-heritability estimation can ‘cancel’ in estimates of genetic correlations, as biases impact 
both the numerator and denominator of the genetic correlation quotient4; 11. We note that while 
under review, two new methods to estimate stratified genetic correlations via GWAS summary 
statistics 36; 37 have been published as alternatives to sLDSC. Those approaches also need 
external reference samples to infer LD-structure in the actual sample, implying the same problem 
as for LDSC (#4 and 5 in Box 1). However, to partially address this problem one method 36 
achieves smaller standard errors than sLDSC through a block diagonalization of the LD matrix. 
A further study is needed to make explicit comparisons with GREML. 
 In conclusion, LDSC may be the best tool for a massive analysis of multiple sets of 
GWAS summary statistics in estimating genetic correlation between complex traits, because of 
its low computing burden and because summary statistics may be available for much larger 
sample sizes than those with individual genotype data. However, LDSC estimates should be 
carefully interpreted, considering the summary points (Box 1). Any interesting findings from 
LDSC analyses should be followed up, where possible, with more detailed analyses using 
individual genotype data and with GREML methods, even though sample sizes with individual 
genotype data may be smaller.  
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FIGURE TITLES AND LEGENDS 
 
Figure 1. The ratio of SE of LDSC estimate to that of GREML estimate using simulated 
phenotypes based on UK Biobank genotypes.  
Bars are 95% CI based on 100 replicates. The unit for the number of SNPs is thousand. This 
result was based on 858K SNPs (after QC) and 10,000 individuals that were randomly selected 
from UK Biobank. SNPs in each bin were randomly drawn from the 858K SNPs independently. 
The number of causal SNPs was 10,000 that were randomly selected in each bin. The true 
simulated value for the genetic correlation was 0.6 and that for the heritability was 0.5 for both 
traits. Overlap (0%, 10% and 20%) stands for the percentage of overlapping individuals in the 
first and second traits. 
 Figure 2. Estimated genetic correlation with GREML and LDSC (without constrain to the 
intercept) based on different genetic data sets.  
Simulation was based on 10,000 individuals that were randomly selected from UKBB, 
WTCCC2, GERA and UKBBr (the raw genotype of UKBB), with 858K, 432K, 239K, and 124K 
SNPs, respectively. Bars are 95% CI based on 100 replicates. Overlap (0%, 10% and 20%) 
stands for the percentage of overlapping individuals in the first and second traits. The grey 
dashed line stands for the true simulated genetic correlation 0.6. 
 
 Figure 3. Estimated genetic correlation of simulated data based on a genomic partitioning 
model.  
Simulation was based on 10,000 individuals that were randomly selected from UKBB with 858K 
SNP. Based on Gusev et al.24 , the 858K SNPs across the genome were stratified as two 
categories: DHS (194K SNPs with 2268 causal SNPs) and non-DHS (664K SNPs with 7732 
causal SNPs). The genetic correlation for the simulated phenotypes between the first and second 
traits was 0.6 and -0.6 in DHS and non-DHS region, respectively. Bars are 95% CI based on 100 
replicates. LDSC-CEU: Using LD-scores estimated from 1KG reference data. LDSC-OWN: 
Using LD-scores estimated from UKBB. sLDSC-CEU: Using stratified LD-scores estimated 
from 1KG reference data. sLDSC-OWN: Using stratified LD-scores estimated from UKBB. The 
presented results were based on 0% overlapping samples between the first and second traits and 
those based on other scenarios (e.g. 10% and 20%) are presented in Table S1.  
 
 Figure 4. Genetic correlation between SCZ and height and heritability based on SNPs in 
partitioned genomic regions estimated with GREML.  
A joint model was applied by fitting four genomic relationship matrices simultaneously, each 
estimated based on the set of SNPs belong to each of the functional categories (regulatory, 
intron, intergene and DHS). The bars are standard errors. P-value for the estimate significantly 
different from 0 was 0.0028, 0.52, 0.91 and 0.67 for regulatory, intronic, intergenic and DHS 
region, respectively.  
TABLE TITLES AND LEGENDS 
Table 1. Correlation between LD scores estimated based on the HapMap3 SNPs using the 1KG 
CEU reference sample and that from different target populations 
 
Correlation Nr.SNPs 
UKBBa 0.946 858,991 
UKBBrb 0.720 123,615c 
WTCCC2 0.899 421,035c 
GERA 0.661 238,089c 
aUKBB was imputed to the combined data of the 1KG reference and UK10K data.  
bUKBBr was based on the raw genotype data of UK Biobank data. 
cThe number of SNPs reduced further from the set of the QCed SNPs because of using only 
SNPs matched with the HapMap3 SNPs used in calculating LD scores.  
 
Table 2. The ratio of SE of LDSC estimate to that of GREML estimate using simulated 
phenotypes based on UKBB, WTCCC2, GERA and UKBBr genotypes in the scenarios without 
overlapping individuals   
 
800k 400k 200k 100k 
UKBB 1.60(0.15) 1.70 (0.18) 1.85 (0.25) 2.04 (0.33) 
WTCCC2 NA 2.15 (0.31) 2.35 (0.43) 2.68 (0.61) 
GERA NA NA 2.87 (0.56) 3.31 (1.17) 
UKBBr NA NA NA 3.74 (0.79) 
Table 3. Heritability and genetic correlation based on different data sets 
Method #SNPs Data 
#individuals h2 BMI 
h2 SCZ (liability 
scale) 
Genetic correlation 
Mean SD Estimate SE Estimate SE Estimate SE P 
GREML 518,992 
UKBB+ 
SCZ(qced) 
152,961 
 
0.184 3.80E-03 0.192 4.39E-03 -0.136 1.74E-02 4.54E-15 
LDSC 516,519 
UKBB+ 
SCZ(qced) 
151,262 1432.7 0.255 1.38E-02 0.280 1.63E-02 -0.173 3.08E-02 1.91E-08 
LDSC-
meta1 
477,163 
UKBB+ 
GIANT+ 
PGCSCZ 
422,499 20226.0 0.111 8.10E-03 0.259 1.28E-02 -0.091 2.44E-02 1.95E-04 
LDSC-
meta2 
1,011,748 
UKBB+ 
GIANT+ 
PGCSCZ 
414,707 32697.8 0.121 6.50E-03 0.261 1.03E-02 -0.087 1.90E-02 4.91E-06 
GREML: Analysis was based on quality controlled genetic data for BMI (from UK Biobank with 111,019 individuals and 518,992 
SNPs) and schizophrenia (from PGC with 41,630 individuals and 518,992 SNPs). 
LDSC: The data sets used in LDSC were the same as in GREML. 
LDSC-meta1: GWAS summary statistics for BMI were based on meta-analysed GWAS results of UKBB individual-level genetic data 
(with 111,019 individuals and 518,992 SNPs) and of GIANT (245,051 individuals and 477,163 SNPs). For SCZ, the GWAS summary 
statistics from the full PGC sample based on 77,096 individuals were used.  
LDSC-meta2: The data sets used in LDSC-meta2 were the same as in LDSC-meta1 except the increased number of SNPs (1,011,748) 
with which its performance was to check.  
Mean and SD of #individuals: Due to different call rates of each SNP, number of individuals for each SNP used in GWAS were 
different. 
